Vatican invested in abortifacient morning-after-pill company for decades, investigation finds | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

Vatican invested in abortifacient morning-after-pill company for decades, investigation finds

The Holy See’s investment management and real estate office (APSA) invested for 20 years in pharmaceutical companies that produced the abortifacient morning-after pill, an investigation by an Italian news outlet found.

Libero Milone, who served as the first auditor general of the Vatican Curia from 2015 to 2017, told Italian broadcaster Rai 3 in an April 26 interview (read transcript of interview here in Italian) that APSA had made investments that “did not correspond to the social doctrine of the Church.”

Rai 3 discovered in its investigation that involved numerous Vatican players that APSA held shares “for a value of about 20 million euros” in two Swiss pharmaceutical companies, Novartis and Roche, that produced the morning-after pill.

Milone said that his office alerted superiors at the Vatican to the “risky” character of the investments and the Novartis shares were sold in 2016.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA